ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Synthesis CDMO Services Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-21O17542
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Synthesis CDMO Services Market Research Report 2024
BUY CHAPTERS

Global Peptide Synthesis CDMO Services Market Research Report 2024

Code: QYRE-Auto-21O17542
Report
June 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Bachem
CordenPharma
PolyPeptide
AmbioPharm
GenScript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec
GL Biochem

Peptide Synthesis CDMO Services Market

Peptide Synthesis CDMO (Contract Development and Manufacturing Organization) services refer to specialized services provided by companies that assist in the development and manufacturing of peptides for pharmaceutical, biotech, and research purposes. These services encompass a range of activities, from the initial design and synthesis of peptides to their large-scale production and regulatory compliance.
The global Peptide Synthesis CDMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide Synthesis CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Peptide Synthesis CDMO Services in Commercial is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Peptide Synthesis CDMO Services include Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Synthesis CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Synthesis CDMO Services.
The Peptide Synthesis CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide Synthesis CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Synthesis CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Synthesis CDMO Services Market Report

Report Metric Details
Report Name Peptide Synthesis CDMO Services Market
Segment by Type
  • GMP Services
  • Non-GMP Services
Segment by Application
  • Commercial
  • Scientific Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, CBL, Piramal Pharma, CPC Scientific, Creative Peptides, Chinese Peptide Company, ChengDu ShengNuo Biotec, AppTec Co., Ltd., GL Biochem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Synthesis CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Synthesis CDMO Services Market report?

Ans: The main players in the Peptide Synthesis CDMO Services Market are Bachem, CordenPharma, PolyPeptide, AmbioPharm, Genscript, Thermo Fisher, USV Peptides, Bio Basic, ScinoPharm, JPT, CBL, Piramal Pharma, CPC Scientific, Creative Peptides, Chinese Peptide Company, ChengDu ShengNuo Biotec, AppTec Co., Ltd., GL Biochem

What are the Application segmentation covered in the Peptide Synthesis CDMO Services Market report?

Ans: The Applications covered in the Peptide Synthesis CDMO Services Market report are Commercial, Scientific Research, Other

What are the Type segmentation covered in the Peptide Synthesis CDMO Services Market report?

Ans: The Types covered in the Peptide Synthesis CDMO Services Market report are GMP Services, Non-GMP Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide Synthesis CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Synthesis CDMO Services Market Perspective (2019-2030)
2.2 Global Peptide Synthesis CDMO Services Growth Trends by Region
2.2.1 Global Peptide Synthesis CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peptide Synthesis CDMO Services Historic Market Size by Region (2019-2024)
2.2.3 Peptide Synthesis CDMO Services Forecasted Market Size by Region (2025-2030)
2.3 Peptide Synthesis CDMO Services Market Dynamics
2.3.1 Peptide Synthesis CDMO Services Industry Trends
2.3.2 Peptide Synthesis CDMO Services Market Drivers
2.3.3 Peptide Synthesis CDMO Services Market Challenges
2.3.4 Peptide Synthesis CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Synthesis CDMO Services Players by Revenue
3.1.1 Global Top Peptide Synthesis CDMO Services Players by Revenue (2019-2024)
3.1.2 Global Peptide Synthesis CDMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Peptide Synthesis CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Synthesis CDMO Services Revenue
3.4 Global Peptide Synthesis CDMO Services Market Concentration Ratio
3.4.1 Global Peptide Synthesis CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Synthesis CDMO Services Revenue in 2023
3.5 Global Key Players of Peptide Synthesis CDMO Services Head office and Area Served
3.6 Global Key Players of Peptide Synthesis CDMO Services, Product and Application
3.7 Global Key Players of Peptide Synthesis CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Synthesis CDMO Services Breakdown Data by Type
4.1 Global Peptide Synthesis CDMO Services Historic Market Size by Type (2019-2024)
4.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Type (2025-2030)
5 Peptide Synthesis CDMO Services Breakdown Data by Application
5.1 Global Peptide Synthesis CDMO Services Historic Market Size by Application (2019-2024)
5.2 Global Peptide Synthesis CDMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peptide Synthesis CDMO Services Market Size (2019-2030)
6.2 North America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peptide Synthesis CDMO Services Market Size by Country (2019-2024)
6.4 North America Peptide Synthesis CDMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Synthesis CDMO Services Market Size (2019-2030)
7.2 Europe Peptide Synthesis CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peptide Synthesis CDMO Services Market Size by Country (2019-2024)
7.4 Europe Peptide Synthesis CDMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Synthesis CDMO Services Market Size (2019-2030)
8.2 Asia-Pacific Peptide Synthesis CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Synthesis CDMO Services Market Size (2019-2030)
9.2 Latin America Peptide Synthesis CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peptide Synthesis CDMO Services Market Size by Country (2019-2024)
9.4 Latin America Peptide Synthesis CDMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Synthesis CDMO Services Market Size (2019-2030)
10.2 Middle East & Africa Peptide Synthesis CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Synthesis CDMO Services Introduction
11.1.4 Bachem Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.1.5 Bachem Recent Development
11.2 CordenPharma
11.2.1 CordenPharma Company Details
11.2.2 CordenPharma Business Overview
11.2.3 CordenPharma Peptide Synthesis CDMO Services Introduction
11.2.4 CordenPharma Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.2.5 CordenPharma Recent Development
11.3 PolyPeptide
11.3.1 PolyPeptide Company Details
11.3.2 PolyPeptide Business Overview
11.3.3 PolyPeptide Peptide Synthesis CDMO Services Introduction
11.3.4 PolyPeptide Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.3.5 PolyPeptide Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide Synthesis CDMO Services Introduction
11.4.4 AmbioPharm Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.4.5 AmbioPharm Recent Development
11.5 Genscript
11.5.1 Genscript Company Details
11.5.2 Genscript Business Overview
11.5.3 Genscript Peptide Synthesis CDMO Services Introduction
11.5.4 Genscript Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.5.5 Genscript Recent Development
11.6 Thermo Fisher
11.6.1 Thermo Fisher Company Details
11.6.2 Thermo Fisher Business Overview
11.6.3 Thermo Fisher Peptide Synthesis CDMO Services Introduction
11.6.4 Thermo Fisher Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.6.5 Thermo Fisher Recent Development
11.7 USV Peptides
11.7.1 USV Peptides Company Details
11.7.2 USV Peptides Business Overview
11.7.3 USV Peptides Peptide Synthesis CDMO Services Introduction
11.7.4 USV Peptides Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.7.5 USV Peptides Recent Development
11.8 Bio Basic
11.8.1 Bio Basic Company Details
11.8.2 Bio Basic Business Overview
11.8.3 Bio Basic Peptide Synthesis CDMO Services Introduction
11.8.4 Bio Basic Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.8.5 Bio Basic Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Details
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm Peptide Synthesis CDMO Services Introduction
11.9.4 ScinoPharm Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.9.5 ScinoPharm Recent Development
11.10 JPT
11.10.1 JPT Company Details
11.10.2 JPT Business Overview
11.10.3 JPT Peptide Synthesis CDMO Services Introduction
11.10.4 JPT Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.10.5 JPT Recent Development
11.11 CBL
11.11.1 CBL Company Details
11.11.2 CBL Business Overview
11.11.3 CBL Peptide Synthesis CDMO Services Introduction
11.11.4 CBL Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.11.5 CBL Recent Development
11.12 Piramal Pharma
11.12.1 Piramal Pharma Company Details
11.12.2 Piramal Pharma Business Overview
11.12.3 Piramal Pharma Peptide Synthesis CDMO Services Introduction
11.12.4 Piramal Pharma Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.12.5 Piramal Pharma Recent Development
11.13 CPC Scientific
11.13.1 CPC Scientific Company Details
11.13.2 CPC Scientific Business Overview
11.13.3 CPC Scientific Peptide Synthesis CDMO Services Introduction
11.13.4 CPC Scientific Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.13.5 CPC Scientific Recent Development
11.14 Creative Peptides
11.14.1 Creative Peptides Company Details
11.14.2 Creative Peptides Business Overview
11.14.3 Creative Peptides Peptide Synthesis CDMO Services Introduction
11.14.4 Creative Peptides Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.14.5 Creative Peptides Recent Development
11.15 Chinese Peptide Company
11.15.1 Chinese Peptide Company Company Details
11.15.2 Chinese Peptide Company Business Overview
11.15.3 Chinese Peptide Company Peptide Synthesis CDMO Services Introduction
11.15.4 Chinese Peptide Company Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.15.5 Chinese Peptide Company Recent Development
11.16 ChengDu ShengNuo Biotec
11.16.1 ChengDu ShengNuo Biotec Company Details
11.16.2 ChengDu ShengNuo Biotec Business Overview
11.16.3 ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Introduction
11.16.4 ChengDu ShengNuo Biotec Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.16.5 ChengDu ShengNuo Biotec Recent Development
11.17 AppTec Co., Ltd.
11.17.1 AppTec Co., Ltd. Company Details
11.17.2 AppTec Co., Ltd. Business Overview
11.17.3 AppTec Co., Ltd. Peptide Synthesis CDMO Services Introduction
11.17.4 AppTec Co., Ltd. Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.17.5 AppTec Co., Ltd. Recent Development
11.18 GL Biochem
11.18.1 GL Biochem Company Details
11.18.2 GL Biochem Business Overview
11.18.3 GL Biochem Peptide Synthesis CDMO Services Introduction
11.18.4 GL Biochem Revenue in Peptide Synthesis CDMO Services Business (2019-2024)
11.18.5 GL Biochem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Companies
Bachem
CordenPharma
PolyPeptide
AmbioPharm
GenScript
Thermo Fisher
USV Peptides
Bio Basic
ScinoPharm
JPT
CBL
Piramal Pharma
CPC Scientific
Creative Peptides
Chinese Peptide Company
ChengDu ShengNuo Biotec
AppTec
GL Biochem
List of Tables
 Table 1. Global Peptide Synthesis CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of GMP Services
 Table 3. Key Players of Non-GMP Services
 Table 4. Global Peptide Synthesis CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Peptide Synthesis CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Peptide Synthesis CDMO Services Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Peptide Synthesis CDMO Services Market Share by Region (2019-2024)
 Table 8. Global Peptide Synthesis CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Peptide Synthesis CDMO Services Market Share by Region (2025-2030)
 Table 10. Peptide Synthesis CDMO Services Market Trends
 Table 11. Peptide Synthesis CDMO Services Market Drivers
 Table 12. Peptide Synthesis CDMO Services Market Challenges
 Table 13. Peptide Synthesis CDMO Services Market Restraints
 Table 14. Global Peptide Synthesis CDMO Services Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Peptide Synthesis CDMO Services Market Share by Players (2019-2024)
 Table 16. Global Top Peptide Synthesis CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Synthesis CDMO Services as of 2023)
 Table 17. Ranking of Global Top Peptide Synthesis CDMO Services Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Peptide Synthesis CDMO Services Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Peptide Synthesis CDMO Services, Headquarters and Area Served
 Table 20. Global Key Players of Peptide Synthesis CDMO Services, Product and Application
 Table 21. Global Key Players of Peptide Synthesis CDMO Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Peptide Synthesis CDMO Services Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2019-2024)
 Table 25. Global Peptide Synthesis CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Peptide Synthesis CDMO Services Revenue Market Share by Type (2025-2030)
 Table 27. Global Peptide Synthesis CDMO Services Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2019-2024)
 Table 29. Global Peptide Synthesis CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Peptide Synthesis CDMO Services Revenue Market Share by Application (2025-2030)
 Table 31. North America Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Peptide Synthesis CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Peptide Synthesis CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Peptide Synthesis CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Peptide Synthesis CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Peptide Synthesis CDMO Services Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Peptide Synthesis CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Peptide Synthesis CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Peptide Synthesis CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Peptide Synthesis CDMO Services Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Bachem Company Details
 Table 47. Bachem Business Overview
 Table 48. Bachem Peptide Synthesis CDMO Services Product
 Table 49. Bachem Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 50. Bachem Recent Development
 Table 51. CordenPharma Company Details
 Table 52. CordenPharma Business Overview
 Table 53. CordenPharma Peptide Synthesis CDMO Services Product
 Table 54. CordenPharma Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 55. CordenPharma Recent Development
 Table 56. PolyPeptide Company Details
 Table 57. PolyPeptide Business Overview
 Table 58. PolyPeptide Peptide Synthesis CDMO Services Product
 Table 59. PolyPeptide Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 60. PolyPeptide Recent Development
 Table 61. AmbioPharm Company Details
 Table 62. AmbioPharm Business Overview
 Table 63. AmbioPharm Peptide Synthesis CDMO Services Product
 Table 64. AmbioPharm Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 65. AmbioPharm Recent Development
 Table 66. Genscript Company Details
 Table 67. Genscript Business Overview
 Table 68. Genscript Peptide Synthesis CDMO Services Product
 Table 69. Genscript Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 70. Genscript Recent Development
 Table 71. Thermo Fisher Company Details
 Table 72. Thermo Fisher Business Overview
 Table 73. Thermo Fisher Peptide Synthesis CDMO Services Product
 Table 74. Thermo Fisher Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 75. Thermo Fisher Recent Development
 Table 76. USV Peptides Company Details
 Table 77. USV Peptides Business Overview
 Table 78. USV Peptides Peptide Synthesis CDMO Services Product
 Table 79. USV Peptides Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 80. USV Peptides Recent Development
 Table 81. Bio Basic Company Details
 Table 82. Bio Basic Business Overview
 Table 83. Bio Basic Peptide Synthesis CDMO Services Product
 Table 84. Bio Basic Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 85. Bio Basic Recent Development
 Table 86. ScinoPharm Company Details
 Table 87. ScinoPharm Business Overview
 Table 88. ScinoPharm Peptide Synthesis CDMO Services Product
 Table 89. ScinoPharm Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 90. ScinoPharm Recent Development
 Table 91. JPT Company Details
 Table 92. JPT Business Overview
 Table 93. JPT Peptide Synthesis CDMO Services Product
 Table 94. JPT Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 95. JPT Recent Development
 Table 96. CBL Company Details
 Table 97. CBL Business Overview
 Table 98. CBL Peptide Synthesis CDMO Services Product
 Table 99. CBL Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 100. CBL Recent Development
 Table 101. Piramal Pharma Company Details
 Table 102. Piramal Pharma Business Overview
 Table 103. Piramal Pharma Peptide Synthesis CDMO Services Product
 Table 104. Piramal Pharma Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 105. Piramal Pharma Recent Development
 Table 106. CPC Scientific Company Details
 Table 107. CPC Scientific Business Overview
 Table 108. CPC Scientific Peptide Synthesis CDMO Services Product
 Table 109. CPC Scientific Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 110. CPC Scientific Recent Development
 Table 111. Creative Peptides Company Details
 Table 112. Creative Peptides Business Overview
 Table 113. Creative Peptides Peptide Synthesis CDMO Services Product
 Table 114. Creative Peptides Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 115. Creative Peptides Recent Development
 Table 116. Chinese Peptide Company Company Details
 Table 117. Chinese Peptide Company Business Overview
 Table 118. Chinese Peptide Company Peptide Synthesis CDMO Services Product
 Table 119. Chinese Peptide Company Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 120. Chinese Peptide Company Recent Development
 Table 121. ChengDu ShengNuo Biotec Company Details
 Table 122. ChengDu ShengNuo Biotec Business Overview
 Table 123. ChengDu ShengNuo Biotec Peptide Synthesis CDMO Services Product
 Table 124. ChengDu ShengNuo Biotec Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 125. ChengDu ShengNuo Biotec Recent Development
 Table 126. AppTec Co., Ltd. Company Details
 Table 127. AppTec Co., Ltd. Business Overview
 Table 128. AppTec Co., Ltd. Peptide Synthesis CDMO Services Product
 Table 129. AppTec Co., Ltd. Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 130. AppTec Co., Ltd. Recent Development
 Table 131. GL Biochem Company Details
 Table 132. GL Biochem Business Overview
 Table 133. GL Biochem Peptide Synthesis CDMO Services Product
 Table 134. GL Biochem Revenue in Peptide Synthesis CDMO Services Business (2019-2024) & (US$ Million)
 Table 135. GL Biochem Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Peptide Synthesis CDMO Services Picture
 Figure 2. Global Peptide Synthesis CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Peptide Synthesis CDMO Services Market Share by Type: 2023 VS 2030
 Figure 4. GMP Services Features
 Figure 5. Non-GMP Services Features
 Figure 6. Global Peptide Synthesis CDMO Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Peptide Synthesis CDMO Services Market Share by Application: 2023 VS 2030
 Figure 8. Commercial Case Studies
 Figure 9. Scientific Research Case Studies
 Figure 10. Other Case Studies
 Figure 11. Peptide Synthesis CDMO Services Report Years Considered
 Figure 12. Global Peptide Synthesis CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Peptide Synthesis CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Peptide Synthesis CDMO Services Market Share by Region: 2023 VS 2030
 Figure 15. Global Peptide Synthesis CDMO Services Market Share by Players in 2023
 Figure 16. Global Top Peptide Synthesis CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Synthesis CDMO Services as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Peptide Synthesis CDMO Services Revenue in 2023
 Figure 18. North America Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Peptide Synthesis CDMO Services Market Share by Country (2019-2030)
 Figure 20. United States Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Peptide Synthesis CDMO Services Market Share by Country (2019-2030)
 Figure 24. Germany Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Peptide Synthesis CDMO Services Market Share by Region (2019-2030)
 Figure 32. China Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Peptide Synthesis CDMO Services Market Share by Country (2019-2030)
 Figure 40. Mexico Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Peptide Synthesis CDMO Services Market Share by Country (2019-2030)
 Figure 44. Turkey Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Peptide Synthesis CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Bachem Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 48. CordenPharma Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 49. PolyPeptide Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 50. AmbioPharm Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 51. Genscript Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 52. Thermo Fisher Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 53. USV Peptides Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 54. Bio Basic Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 55. ScinoPharm Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 56. JPT Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 57. CBL Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 58. Piramal Pharma Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 59. CPC Scientific Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 60. Creative Peptides Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 61. Chinese Peptide Company Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 62. ChengDu ShengNuo Biotec Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 63. AppTec Co., Ltd. Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 64. GL Biochem Revenue Growth Rate in Peptide Synthesis CDMO Services Business (2019-2024)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Custom Peptide CDMO Services Market Research Report 2024
Global Peptide CDMO Services Market Research Report 2025
Global Peptide API CDMO Services Market Research Report 2025
Global Peptide Drug CDMO Market Research Report 2024
Global Oligonucleotide Drug CDMO Services Market Research Report 2024
Global Chemical CDMO Market Research Report 2024
Global Full Service CDMO Market Research Report 2024
Global Formulation CDMO Services Market Research Report 2024
Global Small Molecule Drug CDMO Services Market Research Report 2024
Global Small Molecules CDMO Services Market Research Report 2024
Global Biologics CDMO Services Market Research Report 2024
Global Antibody Drug CDMO Service Market Research Report 2024
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Global Pharmaceutical CDMO Market Research Report 2025
Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Drug Conjugates PDCs CDMO Service Market Research Report 2024
Global Probiotics CDMO Service Market Research Report 2024
Global Contract Dose Manufacturing Market Insights Forecast to 2030
Global mRNA CDMO Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions